Mifepristone
In this article, five things to know about mifepristone are presented. These are the following: 1. Mifepristone, the drug for medical abortion, became available in Canada in January 2017; 2. Combined mifepristone and misoprostol is safe and highly effective; 3. There are few contraindications for us...
Gespeichert in:
| Veröffentlicht in: | Canadian Medical Association journal (CMAJ) 2018-06, Vol.190 (22), p.E688-E688 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | E688 |
|---|---|
| container_issue | 22 |
| container_start_page | E688 |
| container_title | Canadian Medical Association journal (CMAJ) |
| container_volume | 190 |
| creator | Dunn, Sheila, MD MSc Brooks, Melissa, MD |
| description | In this article, five things to know about mifepristone are presented. These are the following: 1. Mifepristone, the drug for medical abortion, became available in Canada in January 2017; 2. Combined mifepristone and misoprostol is safe and highly effective; 3. There are few contraindications for using mifepristone; 4. Mifepristone abortion can be provided in primary care; and 5. Many government insurance plans cover mifepristone and misoprostol. |
| doi_str_mv | 10.1503/cmaj.180047 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5988520</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A541103253</galeid><els_id>1_s2_0_S082039461830467X</els_id><sourcerecordid>A541103253</sourcerecordid><originalsourceid>FETCH-LOGICAL-c695t-50121e80f59b16ef2132b3b780ac1b625889573009b9972230dfcab9bea6c01f3</originalsourceid><addsrcrecordid>eNqVks9v0zAUxy0EYmXjxJ0DSAiEUp7tOLEvk6aJH5MGSAwkbpbjvrQuid3FycT-exx1dA3qhfgQyf74a_u9DyHPKMypAP7OtmY9pxIgLx-QGc2lzBhn6iGZgWSQcZUXR-RJjGtIH2flY3LElCwKqfIZOfnsatx0LvbB4wl5VJsm4tO7_zH58eH99_NP2eXXjxfnZ5eZLZToMwGUUZRQC1XRAmtGOat4VUowllYFE1IqUXIAVSlVMsZhUVtTqQpNYYHW_JicbnM3Q9XiwqLvO9PodI3WdLc6GKenK96t9DLcaKGkFAxSwOu7gC5cDxh73bposWmMxzBEzUBAqgPjPKEv_0HXYeh8et5IFUCl5PSeWpoGtfN1SOfaMVSfiZzSVDcxZmUHqCV6TJdM9atdmp7wLw7wduOu9T40PwClscDW2YOpbyYbEtPj735phhj1xdW3_2C_TNlXe-wKTdOvYmiG3gUfp-DbLWi7EGOH9a5zFPSopB6V1FslE_18v9k79q-D9zZgUu7GYadt47yzpvmFtxh37aI6Mg36arR6lJpKDnlR_uR_ABNY6GE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2056018831</pqid></control><display><type>article</type><title>Mifepristone</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Journals@Ovid Complete</source><creator>Dunn, Sheila, MD MSc ; Brooks, Melissa, MD</creator><creatorcontrib>Dunn, Sheila, MD MSc ; Brooks, Melissa, MD</creatorcontrib><description>In this article, five things to know about mifepristone are presented. These are the following: 1. Mifepristone, the drug for medical abortion, became available in Canada in January 2017; 2. Combined mifepristone and misoprostol is safe and highly effective; 3. There are few contraindications for using mifepristone; 4. Mifepristone abortion can be provided in primary care; and 5. Many government insurance plans cover mifepristone and misoprostol.</description><identifier>ISSN: 0820-3946</identifier><identifier>EISSN: 1488-2329</identifier><identifier>DOI: 10.1503/cmaj.180047</identifier><identifier>PMID: 29866894</identifier><language>eng</language><publisher>Canada: Joule Inc</publisher><subject>Abortion ; Complications and side effects ; Dosage and administration ; Drugs ; Gynecology ; Insurance coverage ; Internal Medicine ; Menstruation ; Mifepristone ; Practice ; Pregnancy complications ; Pro life movement ; Ultrasonic imaging ; Womens health</subject><ispartof>Canadian Medical Association journal (CMAJ), 2018-06, Vol.190 (22), p.E688-E688</ispartof><rights>Joule Inc. or its licensors</rights><rights>COPYRIGHT 2018 Joule Inc.</rights><rights>Copyright Joule Inc Jun 4, 2018</rights><rights>2018 Joule Inc. or its licensors 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c695t-50121e80f59b16ef2132b3b780ac1b625889573009b9972230dfcab9bea6c01f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988520/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988520/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29866894$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dunn, Sheila, MD MSc</creatorcontrib><creatorcontrib>Brooks, Melissa, MD</creatorcontrib><title>Mifepristone</title><title>Canadian Medical Association journal (CMAJ)</title><addtitle>CMAJ</addtitle><description>In this article, five things to know about mifepristone are presented. These are the following: 1. Mifepristone, the drug for medical abortion, became available in Canada in January 2017; 2. Combined mifepristone and misoprostol is safe and highly effective; 3. There are few contraindications for using mifepristone; 4. Mifepristone abortion can be provided in primary care; and 5. Many government insurance plans cover mifepristone and misoprostol.</description><subject>Abortion</subject><subject>Complications and side effects</subject><subject>Dosage and administration</subject><subject>Drugs</subject><subject>Gynecology</subject><subject>Insurance coverage</subject><subject>Internal Medicine</subject><subject>Menstruation</subject><subject>Mifepristone</subject><subject>Practice</subject><subject>Pregnancy complications</subject><subject>Pro life movement</subject><subject>Ultrasonic imaging</subject><subject>Womens health</subject><issn>0820-3946</issn><issn>1488-2329</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqVks9v0zAUxy0EYmXjxJ0DSAiEUp7tOLEvk6aJH5MGSAwkbpbjvrQuid3FycT-exx1dA3qhfgQyf74a_u9DyHPKMypAP7OtmY9pxIgLx-QGc2lzBhn6iGZgWSQcZUXR-RJjGtIH2flY3LElCwKqfIZOfnsatx0LvbB4wl5VJsm4tO7_zH58eH99_NP2eXXjxfnZ5eZLZToMwGUUZRQC1XRAmtGOat4VUowllYFE1IqUXIAVSlVMsZhUVtTqQpNYYHW_JicbnM3Q9XiwqLvO9PodI3WdLc6GKenK96t9DLcaKGkFAxSwOu7gC5cDxh73bposWmMxzBEzUBAqgPjPKEv_0HXYeh8et5IFUCl5PSeWpoGtfN1SOfaMVSfiZzSVDcxZmUHqCV6TJdM9atdmp7wLw7wduOu9T40PwClscDW2YOpbyYbEtPj735phhj1xdW3_2C_TNlXe-wKTdOvYmiG3gUfp-DbLWi7EGOH9a5zFPSopB6V1FslE_18v9k79q-D9zZgUu7GYadt47yzpvmFtxh37aI6Mg36arR6lJpKDnlR_uR_ABNY6GE</recordid><startdate>20180604</startdate><enddate>20180604</enddate><creator>Dunn, Sheila, MD MSc</creator><creator>Brooks, Melissa, MD</creator><general>Joule Inc</general><general>CMA Impact, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISN</scope><scope>ISR</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FQ</scope><scope>8FV</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M3G</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180604</creationdate><title>Mifepristone</title><author>Dunn, Sheila, MD MSc ; Brooks, Melissa, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c695t-50121e80f59b16ef2132b3b780ac1b625889573009b9972230dfcab9bea6c01f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Abortion</topic><topic>Complications and side effects</topic><topic>Dosage and administration</topic><topic>Drugs</topic><topic>Gynecology</topic><topic>Insurance coverage</topic><topic>Internal Medicine</topic><topic>Menstruation</topic><topic>Mifepristone</topic><topic>Practice</topic><topic>Pregnancy complications</topic><topic>Pro life movement</topic><topic>Ultrasonic imaging</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dunn, Sheila, MD MSc</creatorcontrib><creatorcontrib>Brooks, Melissa, MD</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Canada</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Canadian Business & Current Affairs Database</collection><collection>Canadian Business & Current Affairs Database (Alumni Edition)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>CBCA Reference & Current Events</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Canadian Medical Association journal (CMAJ)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dunn, Sheila, MD MSc</au><au>Brooks, Melissa, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mifepristone</atitle><jtitle>Canadian Medical Association journal (CMAJ)</jtitle><addtitle>CMAJ</addtitle><date>2018-06-04</date><risdate>2018</risdate><volume>190</volume><issue>22</issue><spage>E688</spage><epage>E688</epage><pages>E688-E688</pages><issn>0820-3946</issn><eissn>1488-2329</eissn><abstract>In this article, five things to know about mifepristone are presented. These are the following: 1. Mifepristone, the drug for medical abortion, became available in Canada in January 2017; 2. Combined mifepristone and misoprostol is safe and highly effective; 3. There are few contraindications for using mifepristone; 4. Mifepristone abortion can be provided in primary care; and 5. Many government insurance plans cover mifepristone and misoprostol.</abstract><cop>Canada</cop><pub>Joule Inc</pub><pmid>29866894</pmid><doi>10.1503/cmaj.180047</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0820-3946 |
| ispartof | Canadian Medical Association journal (CMAJ), 2018-06, Vol.190 (22), p.E688-E688 |
| issn | 0820-3946 1488-2329 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5988520 |
| source | DOAJ Directory of Open Access Journals; PubMed Central; Alma/SFX Local Collection; Journals@Ovid Complete |
| subjects | Abortion Complications and side effects Dosage and administration Drugs Gynecology Insurance coverage Internal Medicine Menstruation Mifepristone Practice Pregnancy complications Pro life movement Ultrasonic imaging Womens health |
| title | Mifepristone |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T19%3A46%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mifepristone&rft.jtitle=Canadian%20Medical%20Association%20journal%20(CMAJ)&rft.au=Dunn,%20Sheila,%20MD%20MSc&rft.date=2018-06-04&rft.volume=190&rft.issue=22&rft.spage=E688&rft.epage=E688&rft.pages=E688-E688&rft.issn=0820-3946&rft.eissn=1488-2329&rft_id=info:doi/10.1503/cmaj.180047&rft_dat=%3Cgale_pubme%3EA541103253%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2056018831&rft_id=info:pmid/29866894&rft_galeid=A541103253&rft_els_id=1_s2_0_S082039461830467X&rfr_iscdi=true |